Leadership: Page 5


  • roz Brewer
    Image attribution tooltip

    Permission granted by Roz Brewer

    Image attribution tooltip

    Roz Brewer announces sudden departure as CEO of Walgreens

    The exec who set out to overhaul the long-time pharmacy giant offered few details on why she's stepping down.

    By Sept. 1, 2023
  • Test tube blood
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip
    Q&A // Biotech Spotlight

    ‘We need to do better:’ A biotech CEO on standing apart from the crowd

    The CEO of Cullinan Oncology is taking a small biotech to the next step and believes the temporary financial barriers are smaller than scientific progress.

    By Aug. 29, 2023
  • clinical trial diversity Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Shubh Goel, head of immuno-oncology, gastrointestinal tumors franchise, AstraZeneca
    Image attribution tooltip
    Permission granted by AstraZeneca
    Image attribution tooltip

    How an AstraZeneca exec is leading the charge in the next immuno-oncology era

    The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.

    By Aug. 17, 2023
  • Christy Siegel WoW
    Image attribution tooltip
    Permission granted by Novartis
    Image attribution tooltip
    Podcast

    Woman of the Week: Novartis’ Christy Siegel

    The oncology portfolio general manager for breast and women’s cancers, discusses the company’s recent “landmark” trial and how her family’s history connects her to patients.

    By Taren Grom and Meagan Parrish • Aug. 15, 2023
  • Deborah Dunsire headshot
    Image attribution tooltip
    Permission granted by Lundbeck
    Image attribution tooltip
    Q&A

    5 minutes with — Lundbeck CEO Dr. Deborah Dunsire

    The long-time pharma exec on her most recent wins, her favorite rule to break and the words she lives by.

    By Aug. 11, 2023
  • Weight loss obesity
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    In the era of blockbuster obesity drugs, a personalized approach could boost outcomes

    Ozempic and Wegovy have become household names for weight loss. But obesity is complex, and Phenomix Sciences is looking to bring a personalized medicine approach to the field.

    By Aug. 8, 2023
  • Michael Severino, CEO, Tessera Therapeutics
    Image attribution tooltip
    Permission granted by Tessera
    Image attribution tooltip
    Q&A // Biotech Spotlight

    Why AbbVie’s former president has high hopes for this Flagship-backed biotech

    The CEO of Tessera Therapeutics believes the company’s gene writing technology could eventually cure nearly any genetic disease across patient populations.

    By Karissa Waddick • Aug. 7, 2023
  • Iceberg
    Image attribution tooltip
    Joe Raedle / Staff via Getty Images
    Image attribution tooltip

    New Alzheimer’s treatments are the tip of the iceberg in a long-stymied area of medicine

    A smaller player in the Alzheimer’s space, Prothena is approaching the next phase of treatments, including prevention and clinical trial evolution.

    By Aug. 3, 2023
  • A glass building with a sign that reads,  "Biogen."
    Image attribution tooltip

    Paul Marotta/Sipa USA/Newscom

    Image attribution tooltip

    Biogen’s layoffs are the latest in an industrywide slip

    Over 100 biotech companies so far this year have cut staff due to persistent funding challenges.

    By Karissa Waddick • July 26, 2023
  • Peter Benton
    Image attribution tooltip
    Permission granted by Worldwide Clinical Trials
    Image attribution tooltip
    Q&A

    A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here

    Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.  

    By Taren Grom and Meagan Parrish • July 20, 2023
  • Professional headshot of Colleen Acosta.
    Image attribution tooltip
    Permission granted by Freya Biosciences
    Image attribution tooltip
    Profile

    What the 2014 Ebola outbreak taught this biotech CEO about persuasion

    A former WHO epidemiologist is applying lessons learned during the Ebola epidemic to her work leading a company at the forefront of women’s health: the reproductive microbiome.

    By Alexandra Pecci • July 18, 2023
  • A puzzle with business leader stick figures sits on a wooden desk, with three pieces sitting on the side.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Making Moves

    Flagship, PhRMA prioritize experience in hot summer exec changes

    With major projects brewing at both organizations, these new leaders will hit the ground running. 

    By Karissa Waddick • July 14, 2023
  • bullseye
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A // First 90 Days

    A rare disease veteran, Inozyme’s new CEO sharpens the company’s focus

    After taking the reins from the company’s founding CEO, Douglas Treco is guiding Inozyme through the clinic.

    By Alexandra Pecci • July 11, 2023
  • Colorful drug capsules against a yellow background
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    The stories you’ve read the most in 2023 (so far)

    From staff shortages to presidential candidates and the M&A outlook, here are our most-read stories from the first half of the year.

    By PharmaVoice Staff • July 3, 2023
  • Summer
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    A pharma summer — how leaders unwind and recharge their teams in the warmer months

    Vacation is calling, but so are patients. Here's how the industry adjusts in the summer. 

    By June 30, 2023
  • A photo of Sanofi headquarters in Paris, France.
    Image attribution tooltip
    Courtesy of Sanofi
    Image attribution tooltip
    Q&A

    How Sanofi is taking a ‘creative’ approach to dealmaking

    Dr. Monika Vnuk, SVP of global partnering and business development, is setting her sights on out-of-the-box partnerships.

    By June 23, 2023
  • microscope
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    DIA’s chief exec is on a mission to grow its footprint across healthcare

    Marwan Fathallah came onboard earlier this year to lead the organization into an era of change.

    By June 22, 2023
  • LGBTQ flag waves during parade
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    10 years proud: Pharma’s top companies for LGBTQ+ inclusivity

    These six Big Pharma companies have ranked among the best places to work for LGTBQ+ equality by the Human Rights Campaign Foundation for over 10 years. Here’s why. 

    By Karissa Waddick , June 22, 2023
  • Professional headshot of Court Horncastle
    Image attribution tooltip
    Permission granted by GSK
    Image attribution tooltip
    Profile

    Duty to serve: an Army officer’s unexpected path to GSK

    How Court Horncastle, SVP, business unit head of the anti-infective and respiratory team at GSK, applies lessons from combat to his work in antibiotics.

    By Alexandra Pecci • June 21, 2023
  • Reenie McCarthy Stealth BioTherapeutics
    Image attribution tooltip
    Permission granted by Reenie McCarthy Stealth BioTherapeutics
    Image attribution tooltip
    Podcast

    Woman of the Week: Stealth BioTherapeutics’ Reenie McCarthy

    How the CEO navigated a regulatory odyssey to bring the company’s lead program for an ultra-rare disease to a fast track approval.

    By June 21, 2023
  • syringes on blue
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    Shaking up pharma: Change that leaders would like to see

    Industry execs give voice to the “game changers” they believe would have the greatest impact on the healthcare ecosystem for all.

    By June 16, 2023
  • Abbey Jenkins Gamida Cell
    Image attribution tooltip
    Permission granted by Abbey Jenkins Gamida Cell
    Image attribution tooltip
    Podcast

    Woman of the Week: Gamida Cell’s Abbey Jenkins

    The first-time CEO discusses the lessons she has learned since taking the role last year and how she’s pivoting the company into a commercial entity.

    By June 14, 2023
  • hands holding four multicolored gears next to each other horizontally like puzzle pieces
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    The ingredients of a successful biopharma collaboration

    Collaboration is important along the entire spectrum and lifecycle of biopharma, and finding an effective partner is harder than it sounds.

    By June 13, 2023
  • Pharma reputation broken pill
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Yes, biopharma still has a reputation problem. These leaders are looking for solutions.

    Negative news is breaking down the public’s perception of the biopharma industry — but leaders around the industry have some ideas to fix it.

    By June 8, 2023
  • lightbulb pill
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    Ranking reveals biopharma’s most innovative companies

    IDEA Pharma’s 12th index finds that Pfizer and AstraZeneca reign supreme again.

    By June 7, 2023